Evaluating the health and economic outcomes of a PCV15 vaccination program for adults aged 65 years-and-above in Switzerland. Owusu-Edusei K, Favre-Bulle A, Tsoumani E, Mutschler T, et al. Vaccine 2024 Apr 11:S0264-410X(24)00431-6. doi: 10.1016/j.vaccine.2024.

Read + Share

Amedeo Smart

Independent Medical Education

Owusu-Edusei K, Favre-Bulle A, Tsoumani E, Mutschler T, et al. Evaluating the health and economic outcomes of a PCV15 vaccination program for adults aged 65 years-and-above in Switzerland. Vaccine 2024 Apr 11:S0264-410X(24)00431-6. doi: 10.1016/j.vaccine.2024.
PMID: 38609806